Naturally occurring R225W mutation of the gene encoding AMP-activated protein kinase (AMPK)gamma(3) results in increased oxidative capacity and glucose uptake in human primary myotubes.
OBJECTIVE
AMP-activated protein kinase (AMPK) has a broad role in the regulation of glucose and lipid metabolism making it a promising target in the treatment of type 2 diabetes mellitus. We therefore sought to characterise for the first time the effects of chronic AMPK activation on skeletal muscle carbohydrate metabolism in carriers of the rare gain-of-function mutation of the gene encoding AMPKgamma(3) subunit, PRKAG3 R225W.


METHODS
Aspects of fuel metabolism were studied in vitro in myocytes isolated from vastus lateralis of PRKAG3 R225W carriers and matched control participants. In vivo, muscular strength and fatigue were evaluated by isokinetic dynamometer and surface electromyography, respectively. Glucose uptake in exercising quadriceps was determined using [(18)F]fluorodeoxyglucose and positron emission tomography.


RESULTS
Myotubes from PRKAG3 R225W carriers had threefold higher mitochondrial content (p < 0.01) and oxidative capacity, higher leak-dependent respiration (1.6-fold, p < 0.05), higher basal glucose uptake (twofold, p < 0.01) and higher glycogen synthesis rates (twofold, p < 0.05) than control myotubes. They also had higher levels of intracellular glycogen (p < 0.01) and a trend for lower intramuscular triacylglycerol stores. R225W carriers showed remarkable resistance to muscular fatigue and a trend for increased glucose uptake in exercising muscle in vivo.


CONCLUSIONS
Through the enhancement of skeletal muscle glucose uptake and increased mitochondrial content, the R225W mutation may significantly enhance exercise performance. These findings are also consistent with the hypothesis that the gamma(3) subunit of AMPK is a promising tissue-specific target for the treatment of type 2 diabetes mellitus, a condition in which glucose uptake and mitochondrial function are impaired.
Crawford
S A
SA
Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Costford
S R
SR
Aguer
C
C
Thomas
S C
SC
deKemp
R A
RA
DaSilva
J N
JN
Lafontaine
D
D
Kendall
M
M
Dent
R
R
Beanlands
R S B
RS
McPherson
R
R
Harper
M-E
ME
D055372:AMP-Activated Protein Kinases / Q000235:genetics* / Q000378:metabolism*; D000328:Adult; D001692:Biological Transport / Q000235:genetics / Q000502:physiology; D015153:Blotting, Western; D002478:Cells, Cultured; D005227:Fatty Acids / Q000378:metabolism; D005947:Glucose / Q000378:metabolism*; D006003:Glycogen / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D008875:Middle Aged; D018485:Muscle Fibers, Skeletal / Q000378:metabolism*; D018482:Muscle, Skeletal / Q000378:metabolism; D009154:Mutation; D010101:Oxygen Consumption / Q000235:genetics / Q000502:physiology; D049268:Positron-Emission Tomography; D020133:Reverse Transcriptase Polymerase Chain Reaction
D005227:Fatty Acids; D006003:Glycogen; C526225:PRKAG3 protein, human; D055372:AMP-Activated Protein Kinases; D005947:Glucose
Diabetes. 2003 May;52(5):1066-72
12716734
FASEB J. 1995 Apr;9(7):541-6
7737463
J Cell Physiol. 2008 Nov;217(2):478-85
18561258
Circ Cardiovasc Genet. 2009 Oct;2(5):457-66
20031621
J Physiol. 2005 Apr 15;564(Pt 2):563-73
15718261
EMBO J. 2005 May 18;24(10):1810-20
15889149
Am J Physiol Regul Integr Comp Physiol. 2003 Apr;284(4):R936-44
12626360
Diabetes. 1999 Aug;48(8):1667-71
10426389
PLoS One. 2007 Sep 19;2(9):e903
17878938
Mol Cell Biol. 2000 Sep;20(18):6704-11
10958668
Diabetes. 2001 Jan;50(1):12-7
11147776
J Biol Chem. 1998 Jun 12;273(24):14767-71
9614076
J Physiol. 2002 Jul 15;542(Pt 2):403-12
12122141
Am J Physiol Cell Physiol. 2004 Feb;286(2):C283-92
14512293
J Biol Chem. 2008 Dec 5;283(49):33902-10
18801732
J Biol Chem. 1980 Mar 25;255(6):2308-14
6102090
N Engl J Med. 2001 Jun 14;344(24):1823-31
11407343
Diabetes. 2008 Nov;57(11):2958-66
18728234
Physiol Rev. 2009 Jul;89(3):1025-78
19584320
Curr Biol. 1994 Apr 1;4(4):315-24
7922340
J Appl Physiol (1985). 2003 Sep;95(3):960-8
12777406
Cell Metab. 2009 Jan 7;9(1):23-34
19117544
FEBS Lett. 1998 Jul 17;431(2):180-4
9708898
Am J Physiol Endocrinol Metab. 2004 Feb;286(2):E194-200
14559719
Nature. 2009 Apr 23;458(7241):1056-60
19262508
J Lipid Res. 2006 Jun;47(6):1281-8
16508037
J Clin Endocrinol Metab. 2004 Jul;89(7):3440-8
15240629
Biochem J. 2007 Oct 15;407(2):231-41
17617058
J Biol Chem. 2008 Dec 19;283(51):35724-34
18838377
J Biol Chem. 2001 Dec 14;276(50):46912-6
11598104
Diabetes. 2002 Mar;51(3):567-73
11872652
J Lipid Res. 2007 Apr;48(4):961-7
17213484
Arch Biochem Biophys. 1997 Jan 15;337(2):169-75
9016810
Biochim Biophys Acta. 1989 Jun 15;1012(1):81-6
2567185
FASEB J. 2005 May;19(7):773-9
15857891
Am J Physiol. 1999 Aug;277(2):H643-9
10444490
J Appl Physiol (1985). 1999 Nov;87(5):1990-5
10562646
Int J Obes (Lond). 2008 Sep;32 Suppl 4:S7-12
18719601
J Biol. 2003;2(4):28
14511394
J Clin Invest. 2002 Feb;109(3):357-62
11827995
J Biol Chem. 2004 Sep 10;279(37):38441-7
15247217
Circulation. 2001 Dec 18;104(25):3030-3
11748095
Diabetes. 2005 May;54(5):1331-9
15855317
Science. 2000 May 19;288(5469):1248-51
10818001
J Appl Physiol (1985). 2005 Sep;99(3):1189-92
15879164
Am J Physiol Endocrinol Metab. 2000 Nov;279(5):E1039-44
11052958
Mol Cell. 2001 May;7(5):1085-94
11389854
Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12017-22
17609368
Endocrinology. 1973 Sep;93(3):602-9
4352804
J Biol Chem. 2004 Jan 9;279(2):1070-9
14573616